Compile Data Set for Download or QSAR

Found 43 hits Enz. Inhib. hit(s) with all data for entry = 6148   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Homo sapiens (Human))	BDBM111911 (US8623901, 239) Show SMILES Cn1cc(cn1)-c1ccc(F)cc1Cc1nc2n(ncc2c(=O)[nH]1)C1CCOCC1 Show InChI InChI=1S/C21H21FN6O2/c1-27-12-14(10-23-27)17-3-2-15(22)8-13(17)9-19-25-20-18(21(29)26-19)11-24-28(20)16-4-6-30-7-5-16/h2-3,8,10-12,16H,4-7,9H2,1H3,(H,25,26,29)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	2	n/a	n/a	n/a	n/a	7.5	0
Boehringer Ingelheim International GmbH US Patent					Assay Description The PDE9A2 enzymatic activity assay was run as scintillation proximity assay (SPA), in general according to the protocol of the manufacturer (GE Heal...				US Patent US8623901 (2014) BindingDB Entry DOI: 10.7270/Q2Z036TP
					More data for this Ligand-Target Pair
High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Homo sapiens (Human))	BDBM111910 (US8623901, 234) Show SMILES Cc1nnc([nH]1)-c1ccccc1Cc1nc2n(ncc2c(=O)[nH]1)C1CCOCC1 Show InChI InChI=1S/C20H21N7O2/c1-12-22-18(26-25-12)15-5-3-2-4-13(15)10-17-23-19-16(20(28)24-17)11-21-27(19)14-6-8-29-9-7-14/h2-5,11,14H,6-10H2,1H3,(H,22,25,26)(H,23,24,28)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	3	n/a	n/a	n/a	n/a	7.5	0
Boehringer Ingelheim International GmbH US Patent					Assay Description The PDE9A2 enzymatic activity assay was run as scintillation proximity assay (SPA), in general according to the protocol of the manufacturer (GE Heal...				US Patent US8623901 (2014) BindingDB Entry DOI: 10.7270/Q2Z036TP
					More data for this Ligand-Target Pair
High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Homo sapiens (Human))	BDBM111932 (US8623901, 261) Show SMILES COc1ccc(nc1)-c1ccccc1Cc1nc2n(ncc2c(=O)[nH]1)C1CCOCC1 Show InChI InChI=1S/C23H23N5O3/c1-30-17-6-7-20(24-13-17)18-5-3-2-4-15(18)12-21-26-22-19(23(29)27-21)14-25-28(22)16-8-10-31-11-9-16/h2-7,13-14,16H,8-12H2,1H3,(H,26,27,29)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	4	n/a	n/a	n/a	n/a	7.5	0
Boehringer Ingelheim International GmbH US Patent					Assay Description The PDE9A2 enzymatic activity assay was run as scintillation proximity assay (SPA), in general according to the protocol of the manufacturer (GE Heal...				US Patent US8623901 (2014) BindingDB Entry DOI: 10.7270/Q2Z036TP
					More data for this Ligand-Target Pair
High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Homo sapiens (Human))	BDBM111896 (US8623901, 223) Show SMILES O=c1[nH]c(Cc2ccccc2-c2ccc(nc2)N2CCOCC2)nc2n(ncc12)C1CCOCC1 Show InChI InChI=1S/C26H28N6O3/c33-26-22-17-28-32(20-7-11-34-12-8-20)25(22)29-23(30-26)15-18-3-1-2-4-21(18)19-5-6-24(27-16-19)31-9-13-35-14-10-31/h1-6,16-17,20H,7-15H2,(H,29,30,33)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	5	n/a	n/a	n/a	n/a	7.5	0
Boehringer Ingelheim International GmbH US Patent					Assay Description The PDE9A2 enzymatic activity assay was run as scintillation proximity assay (SPA), in general according to the protocol of the manufacturer (GE Heal...				US Patent US8623901 (2014) BindingDB Entry DOI: 10.7270/Q2Z036TP
					More data for this Ligand-Target Pair
High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Homo sapiens (Human))	BDBM111892 (US8623901, 220) Show SMILES COc1cncc(c1)-c1ccccc1Cc1nc2n(ncc2c(=O)[nH]1)C1CCOCC1 Show InChI InChI=1S/C23H23N5O3/c1-30-18-10-16(12-24-13-18)19-5-3-2-4-15(19)11-21-26-22-20(23(29)27-21)14-25-28(22)17-6-8-31-9-7-17/h2-5,10,12-14,17H,6-9,11H2,1H3,(H,26,27,29)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	5	n/a	n/a	n/a	n/a	7.5	0
Boehringer Ingelheim International GmbH US Patent					Assay Description The PDE9A2 enzymatic activity assay was run as scintillation proximity assay (SPA), in general according to the protocol of the manufacturer (GE Heal...				US Patent US8623901 (2014) BindingDB Entry DOI: 10.7270/Q2Z036TP
					More data for this Ligand-Target Pair
High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Homo sapiens (Human))	BDBM111912 (US8623901, 240) Show SMILES O=c1[nH]c(Cc2ccccc2-c2ccccn2)nc2n(ncc12)C1CCOCC1 Show InChI InChI=1S/C22H21N5O2/c28-22-18-14-24-27(16-8-11-29-12-9-16)21(18)25-20(26-22)13-15-5-1-2-6-17(15)19-7-3-4-10-23-19/h1-7,10,14,16H,8-9,11-13H2,(H,25,26,28)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	5	n/a	n/a	n/a	n/a	7.5	0
Boehringer Ingelheim International GmbH US Patent					Assay Description The PDE9A2 enzymatic activity assay was run as scintillation proximity assay (SPA), in general according to the protocol of the manufacturer (GE Heal...				US Patent US8623901 (2014) BindingDB Entry DOI: 10.7270/Q2Z036TP
					More data for this Ligand-Target Pair
High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Homo sapiens (Human))	BDBM111928 (US8623901, 256) Show SMILES Clc1ccc(c(Cc2nc3n(ncc3c(=O)[nH]2)C2CCOCC2)c1)-n1cccn1 Show InChI InChI=1S/C20H19ClN6O2/c21-14-2-3-17(26-7-1-6-22-26)13(10-14)11-18-24-19-16(20(28)25-18)12-23-27(19)15-4-8-29-9-5-15/h1-3,6-7,10,12,15H,4-5,8-9,11H2,(H,24,25,28)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	5	n/a	n/a	n/a	n/a	7.5	0
Boehringer Ingelheim International GmbH US Patent					Assay Description The PDE9A2 enzymatic activity assay was run as scintillation proximity assay (SPA), in general according to the protocol of the manufacturer (GE Heal...				US Patent US8623901 (2014) BindingDB Entry DOI: 10.7270/Q2Z036TP
					More data for this Ligand-Target Pair
High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Homo sapiens (Human))	BDBM111905 (US8623901, 230-2) Show SMILES Cn1cc(cn1)-c1ccccc1Cc1nc2n(ncc2c(=O)[nH]1)C1CCOCC1 Show InChI InChI=1S/C21H22N6O2/c1-26-13-15(11-22-26)17-5-3-2-4-14(17)10-19-24-20-18(21(28)25-19)12-23-27(20)16-6-8-29-9-7-16/h2-5,11-13,16H,6-10H2,1H3,(H,24,25,28)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	5	n/a	n/a	n/a	n/a	7.5	0
Boehringer Ingelheim International GmbH US Patent					Assay Description The PDE9A2 enzymatic activity assay was run as scintillation proximity assay (SPA), in general according to the protocol of the manufacturer (GE Heal...				US Patent US8623901 (2014) BindingDB Entry DOI: 10.7270/Q2Z036TP
					More data for this Ligand-Target Pair
High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Homo sapiens (Human))	BDBM111904 (US8623901, 230-1) Show SMILES O=c1[nH]c(Cc2ccccc2-c2cnc(nc2)N2CCOCC2)nc2n(ncc12)C1CCOCC1 Show InChI InChI=1S/C25H27N7O3/c33-24-21-16-28-32(19-5-9-34-10-6-19)23(21)29-22(30-24)13-17-3-1-2-4-20(17)18-14-26-25(27-15-18)31-7-11-35-12-8-31/h1-4,14-16,19H,5-13H2,(H,29,30,33)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	5	n/a	n/a	n/a	n/a	7.5	0
Boehringer Ingelheim International GmbH US Patent					Assay Description The PDE9A2 enzymatic activity assay was run as scintillation proximity assay (SPA), in general according to the protocol of the manufacturer (GE Heal...				US Patent US8623901 (2014) BindingDB Entry DOI: 10.7270/Q2Z036TP
					More data for this Ligand-Target Pair
High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Homo sapiens (Human))	BDBM111913 (US8623901, 241) Show SMILES Fc1ccc(nc1)-c1ccccc1Cc1nc2n(ncc2c(=O)[nH]1)C1CCOCC1 Show InChI InChI=1S/C22H20FN5O2/c23-15-5-6-19(24-12-15)17-4-2-1-3-14(17)11-20-26-21-18(22(29)27-20)13-25-28(21)16-7-9-30-10-8-16/h1-6,12-13,16H,7-11H2,(H,26,27,29)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	6	n/a	n/a	n/a	n/a	7.5	0
Boehringer Ingelheim International GmbH US Patent					Assay Description The PDE9A2 enzymatic activity assay was run as scintillation proximity assay (SPA), in general according to the protocol of the manufacturer (GE Heal...				US Patent US8623901 (2014) BindingDB Entry DOI: 10.7270/Q2Z036TP
					More data for this Ligand-Target Pair
High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Homo sapiens (Human))	BDBM111894 (US8623901, 221) Show SMILES O=c1[nH]c(Cc2ccccc2-c2ccc(nc2)C#N)nc2n(ncc12)C1CCOCC1 Show InChI InChI=1S/C23H20N6O2/c24-12-17-6-5-16(13-25-17)19-4-2-1-3-15(19)11-21-27-22-20(23(30)28-21)14-26-29(22)18-7-9-31-10-8-18/h1-6,13-14,18H,7-11H2,(H,27,28,30)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	6	n/a	n/a	n/a	n/a	7.5	0
Boehringer Ingelheim International GmbH US Patent					Assay Description The PDE9A2 enzymatic activity assay was run as scintillation proximity assay (SPA), in general according to the protocol of the manufacturer (GE Heal...				US Patent US8623901 (2014) BindingDB Entry DOI: 10.7270/Q2Z036TP
					More data for this Ligand-Target Pair
High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Homo sapiens (Human))	BDBM111907 (US8623901, 230-5) Show SMILES O=c1[nH]c(Cc2ccccc2-c2cc[nH]n2)nc2n(ncc12)C1CCOCC1 Show InChI InChI=1S/C20H20N6O2/c27-20-16-12-22-26(14-6-9-28-10-7-14)19(16)23-18(24-20)11-13-3-1-2-4-15(13)17-5-8-21-25-17/h1-5,8,12,14H,6-7,9-11H2,(H,21,25)(H,23,24,27)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	6	n/a	n/a	n/a	n/a	7.5	0
Boehringer Ingelheim International GmbH US Patent					Assay Description The PDE9A2 enzymatic activity assay was run as scintillation proximity assay (SPA), in general according to the protocol of the manufacturer (GE Heal...				US Patent US8623901 (2014) BindingDB Entry DOI: 10.7270/Q2Z036TP
					More data for this Ligand-Target Pair
High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Homo sapiens (Human))	BDBM111901 (US8623901, 228) Show SMILES Fc1cc(ccn1)-c1ccccc1Cc1nc2n(ncc2c(=O)[nH]1)C1CCOCC1 Show InChI InChI=1S/C22H20FN5O2/c23-19-11-15(5-8-24-19)17-4-2-1-3-14(17)12-20-26-21-18(22(29)27-20)13-25-28(21)16-6-9-30-10-7-16/h1-5,8,11,13,16H,6-7,9-10,12H2,(H,26,27,29)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	6	n/a	n/a	n/a	n/a	7.5	0
Boehringer Ingelheim International GmbH US Patent					Assay Description The PDE9A2 enzymatic activity assay was run as scintillation proximity assay (SPA), in general according to the protocol of the manufacturer (GE Heal...				US Patent US8623901 (2014) BindingDB Entry DOI: 10.7270/Q2Z036TP
					More data for this Ligand-Target Pair
High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Homo sapiens (Human))	BDBM111898 (US8623901, 225) Show SMILES COc1cc(ccn1)-c1ccccc1Cc1nc2n(ncc2c(=O)[nH]1)C1CCOCC1 Show InChI InChI=1S/C23H23N5O3/c1-30-21-13-16(6-9-24-21)18-5-3-2-4-15(18)12-20-26-22-19(23(29)27-20)14-25-28(22)17-7-10-31-11-8-17/h2-6,9,13-14,17H,7-8,10-12H2,1H3,(H,26,27,29)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	6	n/a	n/a	n/a	n/a	7.5	0
Boehringer Ingelheim International GmbH US Patent					Assay Description The PDE9A2 enzymatic activity assay was run as scintillation proximity assay (SPA), in general according to the protocol of the manufacturer (GE Heal...				US Patent US8623901 (2014) BindingDB Entry DOI: 10.7270/Q2Z036TP
					More data for this Ligand-Target Pair
High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Homo sapiens (Human))	BDBM111909 (US8623901, 232) Show SMILES Cc1nc(no1)-c1ccccc1Cc1nc2n(ncc2c(=O)[nH]1)C1CCOCC1 Show InChI InChI=1S/C20H20N6O3/c1-12-22-18(25-29-12)15-5-3-2-4-13(15)10-17-23-19-16(20(27)24-17)11-21-26(19)14-6-8-28-9-7-14/h2-5,11,14H,6-10H2,1H3,(H,23,24,27)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	7	n/a	n/a	n/a	n/a	7.5	0
Boehringer Ingelheim International GmbH US Patent					Assay Description The PDE9A2 enzymatic activity assay was run as scintillation proximity assay (SPA), in general according to the protocol of the manufacturer (GE Heal...				US Patent US8623901 (2014) BindingDB Entry DOI: 10.7270/Q2Z036TP
					More data for this Ligand-Target Pair
High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Homo sapiens (Human))	BDBM111931 (US8623901, 260) Show SMILES O=c1[nH]c(Cc2ccccc2-c2cccc(OC3CCC3)n2)nc2n(ncc12)C1CCOCC1 Show InChI InChI=1S/C26H27N5O3/c32-26-21-16-27-31(18-11-13-33-14-12-18)25(21)29-23(30-26)15-17-5-1-2-8-20(17)22-9-4-10-24(28-22)34-19-6-3-7-19/h1-2,4-5,8-10,16,18-19H,3,6-7,11-15H2,(H,29,30,32)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	7	n/a	n/a	n/a	n/a	7.5	0
Boehringer Ingelheim International GmbH US Patent					Assay Description The PDE9A2 enzymatic activity assay was run as scintillation proximity assay (SPA), in general according to the protocol of the manufacturer (GE Heal...				US Patent US8623901 (2014) BindingDB Entry DOI: 10.7270/Q2Z036TP
					More data for this Ligand-Target Pair
High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Homo sapiens (Human))	BDBM111930 (US8623901, 258) Show SMILES Cc1ccn(n1)-c1ccc(Cl)cc1Cc1nc2n(ncc2c(=O)[nH]1)C1CCOCC1 Show InChI InChI=1S/C21H21ClN6O2/c1-13-4-7-27(26-13)18-3-2-15(22)10-14(18)11-19-24-20-17(21(29)25-19)12-23-28(20)16-5-8-30-9-6-16/h2-4,7,10,12,16H,5-6,8-9,11H2,1H3,(H,24,25,29)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	7	n/a	n/a	n/a	n/a	7.5	0
Boehringer Ingelheim International GmbH US Patent					Assay Description The PDE9A2 enzymatic activity assay was run as scintillation proximity assay (SPA), in general according to the protocol of the manufacturer (GE Heal...				US Patent US8623901 (2014) BindingDB Entry DOI: 10.7270/Q2Z036TP
					More data for this Ligand-Target Pair
High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Homo sapiens (Human))	BDBM111900 (US8623901, 227) Show SMILES COc1ncc(cn1)-c1ccccc1Cc1nc2n(ncc2c(=O)[nH]1)C1CCOCC1 Show InChI InChI=1S/C22H22N6O3/c1-30-22-23-11-15(12-24-22)17-5-3-2-4-14(17)10-19-26-20-18(21(29)27-19)13-25-28(20)16-6-8-31-9-7-16/h2-5,11-13,16H,6-10H2,1H3,(H,26,27,29)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	8	n/a	n/a	n/a	n/a	7.5	0
Boehringer Ingelheim International GmbH US Patent					Assay Description The PDE9A2 enzymatic activity assay was run as scintillation proximity assay (SPA), in general according to the protocol of the manufacturer (GE Heal...				US Patent US8623901 (2014) BindingDB Entry DOI: 10.7270/Q2Z036TP
					More data for this Ligand-Target Pair
High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Homo sapiens (Human))	BDBM111934 (US8623901, 263) Show SMILES Cc1ccc(nc1)-c1ccccc1Cc1nc2n(ncc2c(=O)[nH]1)C1CCOCC1 Show InChI InChI=1S/C23H23N5O2/c1-15-6-7-20(24-13-15)18-5-3-2-4-16(18)12-21-26-22-19(23(29)27-21)14-25-28(22)17-8-10-30-11-9-17/h2-7,13-14,17H,8-12H2,1H3,(H,26,27,29)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	8	n/a	n/a	n/a	n/a	7.5	0
Boehringer Ingelheim International GmbH US Patent					Assay Description The PDE9A2 enzymatic activity assay was run as scintillation proximity assay (SPA), in general according to the protocol of the manufacturer (GE Heal...				US Patent US8623901 (2014) BindingDB Entry DOI: 10.7270/Q2Z036TP
					More data for this Ligand-Target Pair
High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Homo sapiens (Human))	BDBM111899 (US8623901, 226) Show SMILES O=c1[nH]c(Cc2ccccc2-c2ccc(OCc3ccccc3)nc2)nc2n(ncc12)C1CCOCC1 Show InChI InChI=1S/C29H27N5O3/c35-29-25-18-31-34(23-12-14-36-15-13-23)28(25)32-26(33-29)16-21-8-4-5-9-24(21)22-10-11-27(30-17-22)37-19-20-6-2-1-3-7-20/h1-11,17-18,23H,12-16,19H2,(H,32,33,35)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	9	n/a	n/a	n/a	n/a	7.5	0
Boehringer Ingelheim International GmbH US Patent					Assay Description The PDE9A2 enzymatic activity assay was run as scintillation proximity assay (SPA), in general according to the protocol of the manufacturer (GE Heal...				US Patent US8623901 (2014) BindingDB Entry DOI: 10.7270/Q2Z036TP
					More data for this Ligand-Target Pair
High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Homo sapiens (Human))	BDBM111924 (US8623901, 252) Show SMILES Cc1ccn(n1)-c1ccccc1Cc1nc2n(ncc2c(=O)[nH]1)C1CCOCC1 Show InChI InChI=1S/C21H22N6O2/c1-14-6-9-26(25-14)18-5-3-2-4-15(18)12-19-23-20-17(21(28)24-19)13-22-27(20)16-7-10-29-11-8-16/h2-6,9,13,16H,7-8,10-12H2,1H3,(H,23,24,28)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	11	n/a	n/a	n/a	n/a	7.5	0
Boehringer Ingelheim International GmbH US Patent					Assay Description The PDE9A2 enzymatic activity assay was run as scintillation proximity assay (SPA), in general according to the protocol of the manufacturer (GE Heal...				US Patent US8623901 (2014) BindingDB Entry DOI: 10.7270/Q2Z036TP
					More data for this Ligand-Target Pair
High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Homo sapiens (Human))	BDBM111906 (US8623901, 230-3) Show SMILES Fc1ccc(cn1)-c1ccccc1Cc1nc2n(ncc2c(=O)[nH]1)C1CCOCC1 Show InChI InChI=1S/C22H20FN5O2/c23-19-6-5-15(12-24-19)17-4-2-1-3-14(17)11-20-26-21-18(22(29)27-20)13-25-28(21)16-7-9-30-10-8-16/h1-6,12-13,16H,7-11H2,(H,26,27,29)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	11	n/a	n/a	n/a	n/a	7.5	0
Boehringer Ingelheim International GmbH US Patent					Assay Description The PDE9A2 enzymatic activity assay was run as scintillation proximity assay (SPA), in general according to the protocol of the manufacturer (GE Heal...				US Patent US8623901 (2014) BindingDB Entry DOI: 10.7270/Q2Z036TP
					More data for this Ligand-Target Pair
High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Homo sapiens (Human))	BDBM111903 (US8623901, 230) Show SMILES O=c1[nH]c(Cc2ccccc2-c2cncnc2)cc2n(ncc12)C1CCOCC1 Show InChI InChI=1S/C22H21N5O2/c28-22-20-13-25-27(18-5-7-29-8-6-18)21(20)10-17(26-22)9-15-3-1-2-4-19(15)16-11-23-14-24-12-16/h1-4,10-14,18H,5-9H2,(H,26,28)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	12	n/a	n/a	n/a	n/a	7.5	0
Boehringer Ingelheim International GmbH US Patent					Assay Description The PDE9A2 enzymatic activity assay was run as scintillation proximity assay (SPA), in general according to the protocol of the manufacturer (GE Heal...				US Patent US8623901 (2014) BindingDB Entry DOI: 10.7270/Q2Z036TP
					More data for this Ligand-Target Pair
High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Homo sapiens (Human))	BDBM111891 (US8623901, 219) Show SMILES O=c1[nH]c(Cc2ccccc2-c2cccnc2)nc2n(ncc12)C1CCOCC1 Show InChI InChI=1S/C22H21N5O2/c28-22-19-14-24-27(17-7-10-29-11-8-17)21(19)25-20(26-22)12-15-4-1-2-6-18(15)16-5-3-9-23-13-16/h1-6,9,13-14,17H,7-8,10-12H2,(H,25,26,28)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	12	n/a	n/a	n/a	n/a	7.5	0
Boehringer Ingelheim International GmbH US Patent					Assay Description The PDE9A2 enzymatic activity assay was run as scintillation proximity assay (SPA), in general according to the protocol of the manufacturer (GE Heal...				US Patent US8623901 (2014) BindingDB Entry DOI: 10.7270/Q2Z036TP
					More data for this Ligand-Target Pair
High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Homo sapiens (Human))	BDBM111897 (US8623901, 224) Show SMILES O=c1[nH]c(Cc2ccccc2-c2ccncc2)nc2n(ncc12)C1CCOCC1 Show InChI InChI=1S/C22H21N5O2/c28-22-19-14-24-27(17-7-11-29-12-8-17)21(19)25-20(26-22)13-16-3-1-2-4-18(16)15-5-9-23-10-6-15/h1-6,9-10,14,17H,7-8,11-13H2,(H,25,26,28)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	12	n/a	n/a	n/a	n/a	7.5	0
Boehringer Ingelheim International GmbH US Patent					Assay Description The PDE9A2 enzymatic activity assay was run as scintillation proximity assay (SPA), in general according to the protocol of the manufacturer (GE Heal...				US Patent US8623901 (2014) BindingDB Entry DOI: 10.7270/Q2Z036TP
					More data for this Ligand-Target Pair
High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Homo sapiens (Human))	BDBM111902 (US8623901, 229) Show SMILES COc1ccc(cc1)-c1ccccc1Cc1nc2n(ncc2c(=O)[nH]1)C1CCOCC1 Show InChI InChI=1S/C24H24N4O3/c1-30-19-8-6-16(7-9-19)20-5-3-2-4-17(20)14-22-26-23-21(24(29)27-22)15-25-28(23)18-10-12-31-13-11-18/h2-9,15,18H,10-14H2,1H3,(H,26,27,29)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	14	n/a	n/a	n/a	n/a	7.5	0
Boehringer Ingelheim International GmbH US Patent					Assay Description The PDE9A2 enzymatic activity assay was run as scintillation proximity assay (SPA), in general according to the protocol of the manufacturer (GE Heal...				US Patent US8623901 (2014) BindingDB Entry DOI: 10.7270/Q2Z036TP
					More data for this Ligand-Target Pair
High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Homo sapiens (Human))	BDBM111895 (US8623901, 222) Show SMILES O=c1[nH]c(Cc2ccccc2-c2ccc(cc2)C#N)nc2n(ncc12)C1CCOCC1 Show InChI InChI=1S/C24H21N5O2/c25-14-16-5-7-17(8-6-16)20-4-2-1-3-18(20)13-22-27-23-21(24(30)28-22)15-26-29(23)19-9-11-31-12-10-19/h1-8,15,19H,9-13H2,(H,27,28,30)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	15	n/a	n/a	n/a	n/a	7.5	0
Boehringer Ingelheim International GmbH US Patent					Assay Description The PDE9A2 enzymatic activity assay was run as scintillation proximity assay (SPA), in general according to the protocol of the manufacturer (GE Heal...				US Patent US8623901 (2014) BindingDB Entry DOI: 10.7270/Q2Z036TP
					More data for this Ligand-Target Pair
High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Homo sapiens (Human))	BDBM111908 (US8623901, 231) Show SMILES O=c1[nH]c(Cc2ccccc2-n2cccn2)nc2n(ncc12)C1CCOCC1 Show InChI InChI=1S/C20H20N6O2/c27-20-16-13-22-26(15-6-10-28-11-7-15)19(16)23-18(24-20)12-14-4-1-2-5-17(14)25-9-3-8-21-25/h1-5,8-9,13,15H,6-7,10-12H2,(H,23,24,27)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	18	n/a	n/a	n/a	n/a	7.5	0
Boehringer Ingelheim International GmbH US Patent					Assay Description The PDE9A2 enzymatic activity assay was run as scintillation proximity assay (SPA), in general according to the protocol of the manufacturer (GE Heal...				US Patent US8623901 (2014) BindingDB Entry DOI: 10.7270/Q2Z036TP
					More data for this Ligand-Target Pair
High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Homo sapiens (Human))	BDBM111915 (US8623901, 243) Show SMILES FC(F)(F)c1cccc(n1)-c1ccccc1Cc1nc2n(ncc2c(=O)[nH]1)C1CCOCC1 Show InChI InChI=1S/C23H20F3N5O2/c24-23(25,26)19-7-3-6-18(28-19)16-5-2-1-4-14(16)12-20-29-21-17(22(32)30-20)13-27-31(21)15-8-10-33-11-9-15/h1-7,13,15H,8-12H2,(H,29,30,32)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	18	n/a	n/a	n/a	n/a	7.5	0
Boehringer Ingelheim International GmbH US Patent					Assay Description The PDE9A2 enzymatic activity assay was run as scintillation proximity assay (SPA), in general according to the protocol of the manufacturer (GE Heal...				US Patent US8623901 (2014) BindingDB Entry DOI: 10.7270/Q2Z036TP
					More data for this Ligand-Target Pair
High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Homo sapiens (Human))	BDBM111933 (US8623901, 262) Show SMILES Clc1ccc(nc1)-c1ccccc1Cc1nc2n(ncc2c(=O)[nH]1)C1CCOCC1 Show InChI InChI=1S/C22H20ClN5O2/c23-15-5-6-19(24-12-15)17-4-2-1-3-14(17)11-20-26-21-18(22(29)27-20)13-25-28(21)16-7-9-30-10-8-16/h1-6,12-13,16H,7-11H2,(H,26,27,29)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	20	n/a	n/a	n/a	n/a	7.5	0
Boehringer Ingelheim International GmbH US Patent					Assay Description The PDE9A2 enzymatic activity assay was run as scintillation proximity assay (SPA), in general according to the protocol of the manufacturer (GE Heal...				US Patent US8623901 (2014) BindingDB Entry DOI: 10.7270/Q2Z036TP
					More data for this Ligand-Target Pair
High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Homo sapiens (Human))	BDBM111926 (US8623901, 254) Show SMILES O=c1[nH]c(Cc2ccccc2-c2cccnn2)nc2n(ncc12)C1CCOCC1 Show InChI InChI=1S/C21H20N6O2/c28-21-17-13-23-27(15-7-10-29-11-8-15)20(17)24-19(25-21)12-14-4-1-2-5-16(14)18-6-3-9-22-26-18/h1-6,9,13,15H,7-8,10-12H2,(H,24,25,28)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	20	n/a	n/a	n/a	n/a	7.5	0
Boehringer Ingelheim International GmbH US Patent					Assay Description The PDE9A2 enzymatic activity assay was run as scintillation proximity assay (SPA), in general according to the protocol of the manufacturer (GE Heal...				US Patent US8623901 (2014) BindingDB Entry DOI: 10.7270/Q2Z036TP
					More data for this Ligand-Target Pair
High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Homo sapiens (Human))	BDBM111917 (US8623901, 245) Show SMILES Cc1ccc(o1)-c1ccccc1Cc1nc2n(ncc2c(=O)[nH]1)C1CCOCC1 Show InChI InChI=1S/C22H22N4O3/c1-14-6-7-19(29-14)17-5-3-2-4-15(17)12-20-24-21-18(22(27)25-20)13-23-26(21)16-8-10-28-11-9-16/h2-7,13,16H,8-12H2,1H3,(H,24,25,27)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	21	n/a	n/a	n/a	n/a	7.5	0
Boehringer Ingelheim International GmbH US Patent					Assay Description The PDE9A2 enzymatic activity assay was run as scintillation proximity assay (SPA), in general according to the protocol of the manufacturer (GE Heal...				US Patent US8623901 (2014) BindingDB Entry DOI: 10.7270/Q2Z036TP
					More data for this Ligand-Target Pair
High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Homo sapiens (Human))	BDBM111914 (US8623901, 242) Show SMILES FC(F)(F)c1ccc(nc1)-c1ccccc1Cc1nc2n(ncc2c(=O)[nH]1)C1CCOCC1 Show InChI InChI=1S/C23H20F3N5O2/c24-23(25,26)15-5-6-19(27-12-15)17-4-2-1-3-14(17)11-20-29-21-18(22(32)30-20)13-28-31(21)16-7-9-33-10-8-16/h1-6,12-13,16H,7-11H2,(H,29,30,32)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	23	n/a	n/a	n/a	n/a	7.5	0
Boehringer Ingelheim International GmbH US Patent					Assay Description The PDE9A2 enzymatic activity assay was run as scintillation proximity assay (SPA), in general according to the protocol of the manufacturer (GE Heal...				US Patent US8623901 (2014) BindingDB Entry DOI: 10.7270/Q2Z036TP
					More data for this Ligand-Target Pair
High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Homo sapiens (Human))	BDBM111922 (US8623901, 250) Show SMILES FC(F)(F)c1cnn(c1)-c1ccccc1Cc1nc2n(ncc2c(=O)[nH]1)C1CCOCC1 Show InChI InChI=1S/C21H19F3N6O2/c22-21(23,24)14-10-25-29(12-14)17-4-2-1-3-13(17)9-18-27-19-16(20(31)28-18)11-26-30(19)15-5-7-32-8-6-15/h1-4,10-12,15H,5-9H2,(H,27,28,31)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	24	n/a	n/a	n/a	n/a	7.5	0
Boehringer Ingelheim International GmbH US Patent					Assay Description The PDE9A2 enzymatic activity assay was run as scintillation proximity assay (SPA), in general according to the protocol of the manufacturer (GE Heal...				US Patent US8623901 (2014) BindingDB Entry DOI: 10.7270/Q2Z036TP
					More data for this Ligand-Target Pair
High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Homo sapiens (Human))	BDBM111916 (US8623901, 244) Show SMILES FC(F)(F)c1ccnc(c1)-c1ccccc1Cc1nc2n(ncc2c(=O)[nH]1)C1CCOCC1 Show InChI InChI=1S/C23H20F3N5O2/c24-23(25,26)15-5-8-27-19(12-15)17-4-2-1-3-14(17)11-20-29-21-18(22(32)30-20)13-28-31(21)16-6-9-33-10-7-16/h1-5,8,12-13,16H,6-7,9-11H2,(H,29,30,32)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	26	n/a	n/a	n/a	n/a	7.5	0
Boehringer Ingelheim International GmbH US Patent					Assay Description The PDE9A2 enzymatic activity assay was run as scintillation proximity assay (SPA), in general according to the protocol of the manufacturer (GE Heal...				US Patent US8623901 (2014) BindingDB Entry DOI: 10.7270/Q2Z036TP
					More data for this Ligand-Target Pair
High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Homo sapiens (Human))	BDBM111919 (US8623901, 247) Show SMILES O=c1[nH]c(Cc2ccccc2-c2ccnnc2)nc2n(ncc12)C1CCOCC1 Show InChI InChI=1S/C21H20N6O2/c28-21-18-13-24-27(16-6-9-29-10-7-16)20(18)25-19(26-21)11-14-3-1-2-4-17(14)15-5-8-22-23-12-15/h1-5,8,12-13,16H,6-7,9-11H2,(H,25,26,28)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	27	n/a	n/a	n/a	n/a	7.5	0
Boehringer Ingelheim International GmbH US Patent					Assay Description The PDE9A2 enzymatic activity assay was run as scintillation proximity assay (SPA), in general according to the protocol of the manufacturer (GE Heal...				US Patent US8623901 (2014) BindingDB Entry DOI: 10.7270/Q2Z036TP
					More data for this Ligand-Target Pair
High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Homo sapiens (Human))	BDBM111921 (US8623901, 249) Show SMILES Cc1ncn(n1)-c1ccccc1Cc1nc2n(ncc2c(=O)[nH]1)C1CCOCC1 Show InChI InChI=1S/C20H21N7O2/c1-13-21-12-26(25-13)17-5-3-2-4-14(17)10-18-23-19-16(20(28)24-18)11-22-27(19)15-6-8-29-9-7-15/h2-5,11-12,15H,6-10H2,1H3,(H,23,24,28)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	28	n/a	n/a	n/a	n/a	7.5	0
Boehringer Ingelheim International GmbH US Patent					Assay Description The PDE9A2 enzymatic activity assay was run as scintillation proximity assay (SPA), in general according to the protocol of the manufacturer (GE Heal...				US Patent US8623901 (2014) BindingDB Entry DOI: 10.7270/Q2Z036TP
					More data for this Ligand-Target Pair
High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Homo sapiens (Human))	BDBM111929 (US8623901, 257) Show SMILES FC(F)(F)c1ccc(c(Cc2nc3n(ncc3c(=O)[nH]2)C2CCOCC2)c1)-n1cccn1 Show InChI InChI=1S/C21H19F3N6O2/c22-21(23,24)14-2-3-17(29-7-1-6-25-29)13(10-14)11-18-27-19-16(20(31)28-18)12-26-30(19)15-4-8-32-9-5-15/h1-3,6-7,10,12,15H,4-5,8-9,11H2,(H,27,28,31)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	31	n/a	n/a	n/a	n/a	7.5	0
Boehringer Ingelheim International GmbH US Patent					Assay Description The PDE9A2 enzymatic activity assay was run as scintillation proximity assay (SPA), in general according to the protocol of the manufacturer (GE Heal...				US Patent US8623901 (2014) BindingDB Entry DOI: 10.7270/Q2Z036TP
					More data for this Ligand-Target Pair
High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Homo sapiens (Human))	BDBM111925 (US8623901, 253) Show SMILES O=c1[nH]c(Cc2ccccc2-n2cccc2)nc2n(ncc12)C1CCOCC1 Show InChI InChI=1S/C21H21N5O2/c27-21-17-14-22-26(16-7-11-28-12-8-16)20(17)23-19(24-21)13-15-5-1-2-6-18(15)25-9-3-4-10-25/h1-6,9-10,14,16H,7-8,11-13H2,(H,23,24,27)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	34	n/a	n/a	n/a	n/a	7.5	0
Boehringer Ingelheim International GmbH US Patent					Assay Description The PDE9A2 enzymatic activity assay was run as scintillation proximity assay (SPA), in general according to the protocol of the manufacturer (GE Heal...				US Patent US8623901 (2014) BindingDB Entry DOI: 10.7270/Q2Z036TP
					More data for this Ligand-Target Pair
High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Homo sapiens (Human))	BDBM111923 (US8623901, 251) Show SMILES FC(F)(F)c1ccn(n1)-c1ccccc1Cc1nc2n(ncc2c(=O)[nH]1)C1CCOCC1 Show InChI InChI=1S/C21H19F3N6O2/c22-21(23,24)17-5-8-29(28-17)16-4-2-1-3-13(16)11-18-26-19-15(20(31)27-18)12-25-30(19)14-6-9-32-10-7-14/h1-5,8,12,14H,6-7,9-11H2,(H,26,27,31)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	38	n/a	n/a	n/a	n/a	7.5	0
Boehringer Ingelheim International GmbH US Patent					Assay Description The PDE9A2 enzymatic activity assay was run as scintillation proximity assay (SPA), in general according to the protocol of the manufacturer (GE Heal...				US Patent US8623901 (2014) BindingDB Entry DOI: 10.7270/Q2Z036TP
					More data for this Ligand-Target Pair
High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Homo sapiens (Human))	BDBM111927 (US8623901, 255) Show SMILES FC(F)(F)c1nc(no1)-c1ccccc1Cc1nc2n(ncc2c(=O)[nH]1)C1CCOCC1 Show InChI InChI=1S/C20H17F3N6O3/c21-20(22,23)19-27-16(28-32-19)13-4-2-1-3-11(13)9-15-25-17-14(18(30)26-15)10-24-29(17)12-5-7-31-8-6-12/h1-4,10,12H,5-9H2,(H,25,26,30)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	41	n/a	n/a	n/a	n/a	7.5	0
Boehringer Ingelheim International GmbH US Patent					Assay Description The PDE9A2 enzymatic activity assay was run as scintillation proximity assay (SPA), in general according to the protocol of the manufacturer (GE Heal...				US Patent US8623901 (2014) BindingDB Entry DOI: 10.7270/Q2Z036TP
					More data for this Ligand-Target Pair
High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Homo sapiens (Human))	BDBM111920 (US8623901, 248) Show SMILES O=c1[nH]c(Cc2ccccc2-n2cncn2)nc2n(ncc12)C1CCOCC1 Show InChI InChI=1S/C19H19N7O2/c27-19-15-10-21-26(14-5-7-28-8-6-14)18(15)23-17(24-19)9-13-3-1-2-4-16(13)25-12-20-11-22-25/h1-4,10-12,14H,5-9H2,(H,23,24,27)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	45	n/a	n/a	n/a	n/a	7.5	0
Boehringer Ingelheim International GmbH US Patent					Assay Description The PDE9A2 enzymatic activity assay was run as scintillation proximity assay (SPA), in general according to the protocol of the manufacturer (GE Heal...				US Patent US8623901 (2014) BindingDB Entry DOI: 10.7270/Q2Z036TP
					More data for this Ligand-Target Pair
High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Homo sapiens (Human))	BDBM111918 (US8623901, 246) Show SMILES O=c1[nH]c(Cc2ccccc2-c2ccco2)nc2n(ncc12)C1CCOCC1 Show InChI InChI=1S/C21H20N4O3/c26-21-17-13-22-25(15-7-10-27-11-8-15)20(17)23-19(24-21)12-14-4-1-2-5-16(14)18-6-3-9-28-18/h1-6,9,13,15H,7-8,10-12H2,(H,23,24,26)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	55	n/a	n/a	n/a	n/a	7.5	0
Boehringer Ingelheim International GmbH US Patent					Assay Description The PDE9A2 enzymatic activity assay was run as scintillation proximity assay (SPA), in general according to the protocol of the manufacturer (GE Heal...				US Patent US8623901 (2014) BindingDB Entry DOI: 10.7270/Q2Z036TP
					More data for this Ligand-Target Pair